Source: PR-INSIDE.COM

Press Release: Syncom Formulations : Newly released market study: Syncom Formulations (India) Ltd (524470) - Financial and Strategic SWOT Analysis Review

(PR-inside.com) Syncom Formulations (India) Ltd (Syncom) is a generic pharmaceutical company. It undertakes the discovery, development, manufacturing and marketing of pharmaceutical formulations. The company's product portfolio includes alpha adrenoceptor agonist, analgesic, antipyretic, anti-inflammatory, anti-ulcer agents, antibiotics and stimulants, among others. Syncom offers products in various formulations such as tablets, capsules, liquids orals, liquid vials and dry vial injections, dry syrups, ointments, inhalers and herbals. The company markets products in more than 15 countries worldwide under brand names such as Ostocrat, Oxycrat, Raftus and Amoxytop. It has its operational presence in Canada, Peru, Panama, Mali, Ghana, Hong Kong, Cambodia, the Philippians, Malaysia, ..

Read full article »
Annual Revenue
$25-100M
Employees
500-1.0K